Besides its expression on myeloma cells, SLAMF7 is also present in immune cells, particularly in natural killer (NK) cells, where it serves as a costimulatory receptor to stimulate innate and adaptive immunity. This evidence concerns the gene SLAMF7 and plasma cell myeloma.